๐๐ฎ๐ซ ๐ฏ๐ข๐๐ฐ ๐จ๐ง ๐๐ก๐ข๐ง๐'๐ฌ ๐ข๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐ฏ๐-๐๐ซ๐ฎ๐ ๐ฌ๐๐๐ญ๐จ๐ซ ๐ซ๐๐ฆ๐๐ข๐ง๐ฌ ๐ฎ๐ง๐๐ก๐๐ง๐ ๐๐
A-share and Hong Kong healthcare stocks have rallied strongly, fueled by a wave of catalysts in AI-driven drug discovery.
However, our portfolio manager, Zeshi, emphasizes that this wonโt be a broad-based "tide lifts all boats" rallyโthe ๐ซ๐๐๐ฅ ๐จ๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ ๐ฐ๐ข๐ฅ๐ฅ ๐ฌ๐ญ๐๐ฆ ๐๐ซ๐จ๐ฆ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐๐ญ๐ฎ๐๐ฅ๐ฅ๐ฒ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ข๐ง๐ ๐จ๐ง ๐ญ๐ก๐๐ข๐ซ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ข๐๐ฅ ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐๐ง๐๐ฌ๐ฌ.
Source: China Asset Management Co., Ltd., as of 2026.09
Risk Disclaimer: Investment involves risk, including possible loss of principal. Any forecasts, projections, or opinions contained herein are for reference only and are not guaranteed to occur. The information in this material reflects prevailing market conditions and our judgment as of the release date, which are subject to change without further notice.
#HealthcareInvesting #Biotech #InnovativeDrugs #AIDrugDiscovery #ChinaAMCInsight #MacroStrategy #HongKongStocks #EmergingMarkets
I dumped my ARL4C data into ScienceBuddy from PhAI Labs, then expanded the trace panel to verify the Python execution record step by step. #ScienceBuddy
Discovery
For open-ended research questions, Atria Dawn Preview breaks down research goals, searches and evaluates sources, compares perspectives, and traces key evidence across sources.
It turns scattered information into structured, citable, and verifiable research findingsโhelping researchers move beyond finding information toward building evidence and forming research judgments.
๐ฅ See Atria Dawn Preview in action.
Wondering why @xbxbyXREAL forces a choice between 120Hz stabilization and HDR mode on xbx a01+ for $299. My #GamingThenVsNow shift is playing Steam Deck on the couch, but choosing one display mode over the other feels like a weird trade-off. #ARGlasses
A scalable robot-data pipeline has to solve three things at once: collect quickly, preserve task-relevant contact information, and train policies that survive deployment. #TwinDEX